Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvancedadvt Regulatory News (ADVT)

Share Price Information for Advancedadvt (ADVT)

Share Price is delayed by 15 minutes
Get Live Data
155.00    0.00 (0.00%)
Bid:
150.00
Ask:
160.00
Spread: 10.00 (6.667%)
Market Cap: £205.95m
ADVT Live PriceLast checked at - London Stock Exchange

Intraday Advancedadvt Share Chart

Investor Presentation

15 Nov 2024 08:30

RNS Number : 4206M
AdvancedAdvT Limited
15 November 2024
Β 

15 November 2024

Β 

AdvancedAdvT Limited

Β 

Investor Presentation

Β 

AdvancedAdvT Limited (AIM: ADVT, "AdvT", "the Group"), the international software solutions provider for the business, compliance, and resource management, is pleased to announce that Vin Murria and Gavin Hugill will provide a live presentation relating to the Investor Presentation via Investor Meet Company on 19 Nov 2024, 10:30 GMT.

Β 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 18 Nov 2024, 09:00 GMT, or at any time during the live presentation.

Β 

Investors can sign up to Investor Meet Company for free and add to meet AdvancedAdvT Limited via:

Β 

https://www.investormeetcompany.com/advancedadvt-limited/register-investor

Β 

Investors who already follow AdvancedAdvT Limited on the Investor Meet Company platform will automatically be invited.

Β 

Β 

Enquiries:

Β 

AdvancedAdvT Limited

Vin Murria, Chairperson

Gavin Hugill, Chief Financial Officer

c/o Meare Consulting

Singer Capital Markets (Nominated Adviser and Broker)

Tel: 020 7496 3000

Philip Davies / Sam Butcher

KK Advisory (Investor Relations)

Tel: 020 7039 1901

Kam BansilΒ 

Β 

Meare ConsultingΒ 

Adrian Duffield

Tel: 07990 858548

Β 

Note to Editors

Β 

AdvancedAdvT Limited (AdvT) provides software solutions and platforms across two business transformational areas: business solutions & healthcare compliance, and human capital management.

Β 

The Group's operations are IBSS (financial management software), CHKS (AI based healthcare intelligence compliance and accreditation software), Retain (global resource planning and talent management software), WFM (workforce management software provider) and Celaton, a machine-learning AI based intelligent process automation ("IPA") platform (inSTREAM).

Β 

AdvT is an agent for change. The Group enables the delivery of Artificial Intelligence ("AI"), data analytics and business intelligence, all of which are key future drivers for growth in these sectors where long term digitisation trends are set to transform the workplace for professionals.Β 

Β 

AdvT is developing both organically and through acquisitions, by expanding its presence across adjacent markets, geographical boundaries and digital sectors.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCUVAWRSUUAARA
Date   Source Headline
13th Jul 20221:18 pmGNWForm 8.3 - [ADVANCEDADVT LIMITED -12 07 2022] - HHL
13th Jul 20229:56 amRNSForm 8.5 (EPT/RI)
12th Jul 20221:51 pmRNSForm 8.3 - M&C SAATCHI
12th Jul 202210:26 amRNSForm 8.5 (EPT/RI)
11th Jul 202210:52 amRNSForm 8.5 (EPT/RI)
8th Jul 202211:59 amRNSForm 8.5 (EPT/RI)
7th Jul 20222:40 pmRNSForm 8.3 - M&C SAATCHI
7th Jul 202211:22 amGNWForm 8.3 - AdvancedAdvT Limited
7th Jul 202211:21 amGNWForm 8.3 - AdvancedAdvT Limited
7th Jul 202210:23 amRNSForm 8.5 (EPT/RI)
6th Jul 202211:11 amRNSForm 8.5 (EPT/RI)
6th Jul 202210:16 amGNWForm 8.3 - AdvancedAdvT Limited
6th Jul 20229:25 amRNSForm 8.5 (EPT/NON-RI)
5th Jul 20229:11 amRNSForm 8.5 (EPT/RI)
4th Jul 20223:01 pmRNSForm 8.3 - NEXT FIFTEEN COMMUNICATIONS GROUP PLC
4th Jul 202210:42 amRNSForm 8.5 (EPT/RI)
4th Jul 20229:52 amRNSForm 8.5 (EPT/NON-RI)
1st Jul 20229:02 amRNSForm 8.5 (EPT/RI)
30th Jun 20222:43 pmRNSForm 8.3 - M&C SAATCHI
29th Jun 20222:50 pmRNSForm 8.3 - M&C SAATCHI
28th Jun 20225:54 pmRNSForm 8.5 (EPT/RI) Replacement
24th Jun 20222:09 pmRNSForm 8.3 - M&C SAATCHI
23rd Jun 20222:47 pmRNSForm 8.3 - M&C SAATCHI
23rd Jun 202211:10 amGNWForm 8.3 - AdvancedAdvT Limited
23rd Jun 202210:48 amRNSForm 8.5 (EPT/RI)
22nd Jun 20223:15 pmRNSForm 8.3 - M&C SAATCHI PLC
21st Jun 20222:09 pmRNSForm 8.3 - M&C SAATCHI
17th Jun 20229:50 amRNSForm 8.5 (EPT/RI)
15th Jun 20225:11 pmRNSForm 8.5 (EPT/NON-RI)
15th Jun 202211:25 amRNSForm 8.5 (EPT/RI)
14th Jun 20222:00 pmRNSPublication of Final Offer Document
14th Jun 20229:30 amRNSForm 8.5 (EPT/RI)
13th Jun 202210:28 amRNSForm 8.5 (EPT/RI)
10th Jun 20221:26 pmRNSForm 8.3 - M&C SAATCHI
9th Jun 20223:14 pmRNSForm 8.3 -M&C SAATCHI
9th Jun 202211:33 amRNSForm 8.5 (EPT/RI)
8th Jun 20224:48 pmRNSForm 8.3 - AdvancedAdvT Limited
8th Jun 20222:35 pmRNSForm 8.3 - M&C Saatchi PLC
8th Jun 202210:10 amRNSForm 8.5 (EPT/RI)
7th Jun 202210:04 amRNSForm 8.5 (EPT/RI)
6th Jun 202212:00 pmRNSValuation of competing proposals for M&C Saatchi
6th Jun 202211:38 amRNSForm 8.5 (EPT/RI)
30th May 202211:52 amRNSForm 8.5 (EPT/RI)
26th May 20229:25 amRNSForm 8.5 (EPT/RI)
25th May 20226:18 pmRNSForm 8.5 (EPT/RI) Replacement announcement
25th May 202212:42 pmRNSForm 8.3 - AdvancedAdvT Limited
25th May 202211:05 amRNSForm 8.5 (EPT/RI)
24th May 20224:28 pmRNSForm 8.3 - AdvancedAdvT Limited
24th May 20222:36 pmRNSForm 8.3 - M&C SAATCHI
24th May 202212:12 pmRNSForm 8.3 - AdvancedAdvT Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.